Tag: Cancer: Rectal
Risk Factors Found for Neurogenic Bladder After Rectal Cancer Surgery
Lower abdominal visceral fat area and prolonged surgery are independent risk factors
ACG: GLP-1 RAs Tied to Lower Risk for Early-Onset Colorectal Cancer
Findings seen in people with type 2 diabetes
ACG: 2000 to 2022 Saw Rise in Early-Onset CRC Mortality in the United States
Increase in mortality seen in both early- and late-stage tumors
Cell-Free Blood DNA Tests Less Effective Than Other CRC Screening
cf-bDNA costs $89,600 per quality-adjusted life year gained, with alternatives less costly and more effective
Restaging MRI Can Predict Survival With Rectal Cancer
Findings can save some lower-risk patients surgery after chemo, radiation
FIT Completion, Yield Rates Similar in Those Aged 45 to 49 Versus 50 Years
For individuals aged 45 to 49 years, FIT completion slightly higher while FIT positivity slightly lower
2021 USPSTF Recommendation Boosted Colorectal Cancer Screening
Potential disparities in uptake seen by socioeconomic status and locality among privately insured adults
Long-Course Chemoradiotherapy Preferred TNT Regimen for Rectal Cancer
LCCRT results in higher two-year organ preservation and lower two-year local regrowth compared with short-course radiotherapy
Omitting 5-FU Bolus Does Not Reduce Survival in Advanced Cancer
However, omission does result in reductions in neutropenia, thrombocytopenia, and use of granulocyte colony-stimulating factor
Breast Cancer Screening Attendance Helps Boost Other Cancer Screenings
Findings seen for women offered self-sampling kits for overdue cancer screenings
